Guerbet S.A (GBT) | Stock Overview & Key Data
Guerbet S.A. | Mid-cap | Healthcare
Guerbet S.A. | Mid-cap | Healthcare
Guerbet S.A Performance Comparison
Stock Range
Today's Range
Low: €20.85
High: €21.30
on August 8, 2025
52 Week Range
Low: €17.42
High: €39.35
on April 7, 2025
on October 21, 2024
All-Time High: €90.64 on March 27, 2017
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€260.9M
EPS
1.27
P/E Ratio (TTM)
16.30
Forward P/E
6.29
P/B Ratio
0.66
PEG Ratio
6.29
Div. Yield
2.31%
ROE
3.50%
Beta
0.790
Debt to Equity
100.91
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
4.34%
Profit Margin
1.89%
Returns and Earnings
Return on Assets (TTM)
2.96%
Return on Equity (TTM)
3.50%
EBITDA
€114.3M
Net Income (TTM)
€16.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€67.53
Quarterly Revenue Growth (YoY)
2.50%
Quarterly Earnings Growth (YoY)
-76.60%
Dividend Information
Last 12-Month Dividend
€0.50
Current Dividend Yield
2.31%
3-Year Average Dividend Yield
2.72%
3-Year Average Annual Dividend
€0.62
3-Year Total Dividends
€1.85
Ex-Dividend Date
July 1, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Guerbet S.A GBT | 260.87M Mid-cap | 0.24% | -8.28% | 2.68% | -19.04% | -21.46% | -37.44% | 0.72% | -27.41% |
| Eurobio Scientific ALERS | 251.86M Mid-cap | -1.18% | -0.59% | -0.79% | -1.57% | -0.79% | 2.03% | 31.97% | 134.58% |
| Affluent Medical AFME | 53.93M Small-cap | 3.76% | 1.47% | 6.15% | 2.99% | -0.72% | -25.81% | -56.88% | -82.64% |
| Median Technologies ALMDT | 39.84M Small-cap | -23.92% | -9.77% | -11.01% | -35.55% | -54.25% | -63.60% | -83.22% | -69.69% |
| Novacyt S.A ALNOV | 31.29M Small-cap | -2.17% | -6.25% | 0.00% | -25.00% | -26.23% | -16.67% | -66.67% | -86.69% |
| Diagnostic Medical ALDMS | 26.64M Small-cap | -3.62% | 4.72% | 35.71% | 47.78% | 68.35% | 38.54% | 14.66% | -13.64% |
Ownership & Short Interest
Insider Ownership
58.17%
Institutional Ownership
17.96%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
14K
Average 90-Day Volume
16K
Guerbet S.A Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Guerbet S.A would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is GBT's 52-week high and low?
- In the last 52 weeks, Guerbet S.A reached a high of €39.35 (on October 21, 2024) and a low of €17.42 (on April 7, 2025).
- What is the market cap and P/E ratio for GBT?
- Curious about Guerbet S.A's size and valuation? Its market capitalization stands at 260.87M. When it comes to valuation, the P/E ratio (trailing twelve months) is 16.30, and the forward P/E (looking ahead) is 6.29.
- Does GBT pay dividends? If so, what's the yield?
- Yes, Guerbet S.A is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 2.31%, and the company has paid an average of €0.62 per share annually over the past 3 years.
- Who are Guerbet S.A's main competitors or similar companies to consider before investing?
When looking at Guerbet S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Eurobio Scientific
ALERS251.86M Healthcare Medical Devices 2.03% 31.97% Affluent Medical
AFME53.93M Healthcare Medical Devices -25.81% -56.88% Median Technologies
ALMDT39.84M Healthcare Medical Devices -63.60% -83.22% Novacyt S.A
ALNOV31.29M Healthcare Medical Devices -16.67% -66.67% Diagnostic Medical
ALDMS26.64M Healthcare Medical Devices 38.54% 14.66% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Guerbet S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Guerbet S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 3.50%, the Debt to Equity ratio from the most recent quarter is 100.91, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for GBT?
- Looking at Guerbet S.A's growth, its revenue over the trailing twelve months (TTM) was €851M. Compared to the same quarter last year (YoY), quarterly revenue grew by 2.50%, and quarterly earnings saw a YoY growth of -76.60%.
- How much of GBT stock is held by insiders and institutions?
- Wondering who owns Guerbet S.A stock? Company insiders (like executives and directors) hold about 58.17% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 17.96%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.